Clinical Trials Logo

Clinical Trial Summary

Infraorbital nerve enlargement (IONE) on magnetic resonance imaging is known to be a possible consequence of IgG4-related ophthalmic disease. However this imaging sign can also be found in other conditions causing orbital inflammation. This study aims at comparing the frequency of IONE in patients suffering from IgG4-related ophthalmic disease (IgG4-ROD) versus patients suffering from non-IgG4-related ophthalmic disease (non-IgG4-ROD)


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03690908
Study type Observational
Source Fondation Ophtalmologique Adolphe de Rothschild
Contact
Status Completed
Phase
Start date March 1, 2016
Completion date December 1, 2016

See also
  Status Clinical Trial Phase
Recruiting NCT03368274 - To Evaluate the Clinical Efficacy of Iguratimod in the Treatment of IgG4 Related Disease (IgG4-RD) With Mild Symptom Phase 4
Not yet recruiting NCT03267875 - A Laboratory Scan of Patients With Aortic Aneurysms to IgG4 Levels in the Blood N/A
Completed NCT02616705 - Bile Usefulness for Detecting IgG4-related Sclerosing Cholangitis
Completed NCT03669861 - Safety and Efficacy of Abatacept in IgG4-Related Disease Phase 2
Recruiting NCT05625581 - Tofatib Treatment for IgG4-related Disease
Recruiting NCT04125511 - Characterizing IgG4-RD With 68Ga-FAPI PET/CT Early Phase 1
Not yet recruiting NCT06285539 - Drug Rediscovery for Rare Immune Mediated Inflammatory Diseases Phase 2
Not yet recruiting NCT05746689 - Study of Sirolimus in IgG4-related Disease N/A
Completed NCT02899039 - Follicular Helper T Cells: Biological Marker and Involvement in the Physiopathology of the IgG4-related Disease N/A
Recruiting NCT04660565 - Belimumab Treatment for IgG4-related Disease Phase 4
Recruiting NCT01670695 - A Prospective Cohort Study of IgG4RD in China N/A
Recruiting NCT03023371 - National Registry of IgG4-RD in China N/A
Unknown status NCT01758393 - Glucocorticoids in Patients With IgG4-RD Phase 2/Phase 3
Completed NCT02705638 - Treatment of IgG4-Related Disease With Revlimid and Rituximab Phase 1
Recruiting NCT03473912 - Meir Medical Center Rheumatologic Biobank
Not yet recruiting NCT03466970 - Plasmablast Detection From IgG4-Related Disease Patients N/A